Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

CompletedOBSERVATIONAL

Enrollment

144

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

November 29, 2017

Study Completion Date

November 29, 2017

Conditions

Meningococcal DiseaseInfections, Meningococcal

Interventions

BIOLOGICAL

Meningococcal quadrivalent CRM-197 conjugate vaccine

This study is strictly observational. Decisions of vaccination are made by health care providers.

Trial Locations (1)

GSK Investigational Site, Pasadena